TRUIST FINANCIAL CORP

Truist’s latest equity research uncovers hidden risks and growth levers across banks, REITs, tourism, biotech and consumer goods, offering investors sharper insights for smarter portfolio decisions.

Truist Financial Corp. trades at $49.66, a mid‑range P/E of 13.12, offering defensive value amid stable earnings, strong capital ratios, and growth prospects in digital banking, green financing, and RegTech.

Truist Financial’s latest disclosure shows how its robust retail, commercial, and asset‑management core plus disciplined equity‑research drives resilient growth and sharp valuation insights, positioning it to navigate market dynamics and seize new o…

Truist’s Q4 2025 earnings fell short of expectations, but a $6 B share‑repurchase plan, strong capital base, and 2027 ROTE target signal confidence. Explore the bank’s cost pressures, regulatory landscape, fintech competition, and digital growth opp…

Truist raises price targets for Landstar and J.B. Hunt, citing modest revenue upside and supply‑chain demand, while noting a potential slowdown in housing‑construction.

Truist Financial’s Q4 earnings release, set for later this week, will gauge its health amid regulatory shifts, mortgage scrutiny, and a digital‑banking push.

Truist Financial’s updated income statement format boosts transparency and clarity, helping investors compare core earnings with peers and strengthen its competitive stance.

Truist Financial’s January equity coverage spotlights Palantir and generative‑AI stocks, emphasizing tech’s growth, data‑analytics power, and inflation‑resilient returns.

Truist Financial’s Q4 analysis: solid 4.5% revenue growth, competitive P/E 13.5, and a 12% insurance margin buffer, but digital lag and real‑estate risk demand action.

Truist lifts targets for Broadcom, NVIDIA, Tesla and Intuitive Surgical while lowering Vericel, adding insight on tech, AI and EV growth, debt, and new direct‑deposit feature.